A new study by scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB) in Hyderabad has revealed how viral ...

HYDERABAD: A study by researchers at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, has identified a ...

Hyderabad’s CCMB has identified how viral RNA structures may accelerate α-synuclein amyloid formation linked to Parkinson’s ...

New information is emerging about Dennis Haskins‘ health following his death at 75. Kimberly Snow, a friend and caretaker of the Saved by the Bell alum, told The New York Times following news of his ...

Rutgers engineers have developed a smart shoe that automatically analyzes how a person walks, a technology that someday could help monitor people with Parkinson's disease, spinal cord injuries, ...

The actor was diagnosed eight years ago, according to his caretaker.

Parkinson’s disease is a brain disorder that gradually affects movement and many other body functions. It develops as nerve ...

Juvmo (tavapadon) offers a novel, selective D1/D5 dopamine receptor partial agonist mechanism for early monotherapy and adjunctive treatment in Parkinson disease.

AbbVie ( ABBV) announced that the U.S. FDA has approved JUVMO (tavapadon) tablets for the treatment of adults with Parkinson's disease, providing a new oral treatment option for a progressive ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first ...

Bengaluru: The US Food and Drug Administration has approved AbbVie's drug for Parkinson's disease in adults, the health ...

The FDA approved the dopamine agonist tavapadon (Juvmo) to treat adults with Parkinson's disease, drugmaker AbbVie announced ...